These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31911537)

  • 1. Assessment of poor functional status and post-acute care needs following primary ovarian cancer debulking surgery.
    Roy AG; Brensinger CM; Latif N; Giuntoli R; Kim S; Morgan M; Ko EM
    Int J Gynecol Cancer; 2020 Feb; 30(2):227-232. PubMed ID: 31911537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frailty in ovarian cancer identified the need for increased postoperative care requirements following cytoreductive surgery.
    Yao T; DeJong SR; McGree ME; Weaver AL; Cliby WA; Kumar A
    Gynecol Oncol; 2019 Apr; 153(1):68-73. PubMed ID: 30612784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive Factors for Surgical Morbidities and Adjuvant Chemotherapy Delay for Advanced Ovarian Cancer Patients Treated by Primary Debulking Surgery or Interval Debulking Surgery.
    Castro BGR; Dos Reis R; Cintra GF; Sousa MMA; Vieira MA; Andrade CEMDC
    Int J Gynecol Cancer; 2018 Oct; 28(8):1520-1528. PubMed ID: 30036229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting non-home discharge in epithelial ovarian cancer patients: External validation of a predictive model.
    Connor EV; Newlin EM; Jelovsek JE; AlHilli MM
    Gynecol Oncol; 2018 Oct; 151(1):129-133. PubMed ID: 30107886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of preoperative nutritional status using BIA-derived phase angle (PhA) in patients with advanced ovarian cancer: Correlation with the extent of cytoreduction and complications.
    Uccella S; Mele MC; Quagliozzi L; Rinninella E; Nero C; Cappuccio S; Cintoni M; Gasbarrini A; Scambia G; Fagotti A
    Gynecol Oncol; 2018 May; 149(2):263-269. PubMed ID: 29550182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unplanned postoperative intensive care unit admission for ovarian cancer cytoreduction is associated with significant decrease in overall survival.
    Ross MS; Burriss ME; Winger DG; Edwards RP; Courtney-Brooks M; Boisen MM
    Gynecol Oncol; 2018 Aug; 150(2):306-310. PubMed ID: 29929924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using evidence to direct quality improvement efforts: Defining the highest impact complications after complex cytoreductive surgery for ovarian cancer.
    Narasimhulu DM; Bews KA; Hanson KT; Chang YH; Dowdy SC; Cliby WA
    Gynecol Oncol; 2020 Feb; 156(2):278-283. PubMed ID: 31785863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discharge Destination as a Predictor of Postoperative Outcomes and Readmission Following Posterior Lumbar Fusion.
    Arrighi-Allisan AE; Neifert SN; Gal JS; Deutsch BC; Caridi JM
    World Neurosurg; 2019 Feb; 122():e139-e146. PubMed ID: 30268552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperatively predicting non-home discharge after surgery for gynecologic malignancy.
    Penn CA; Kamdar NS; Morgan DM; Spencer RJ; Uppal S
    Gynecol Oncol; 2019 Feb; 152(2):293-297. PubMed ID: 30497792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Age on 30-Day Mortality and Morbidity in Patients Undergoing Surgery for Ovarian Cancer.
    Mahdi H; Wiechert A; Lockhart D; Rose PG
    Int J Gynecol Cancer; 2015 Sep; 25(7):1216-23. PubMed ID: 26076218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of adverse discharge disposition in adult spinal deformity and associated costs.
    Passias PG; Poorman GW; Bortz CA; Qureshi R; Diebo BG; Paul JC; Horn SR; Segreto FA; Pyne A; Jalai CM; Lafage V; Bess S; Schwab FJ; Hassanzadeh H
    Spine J; 2018 Oct; 18(10):1845-1852. PubMed ID: 29649611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low preoperative skeletal muscle density is predictive for negative postoperative outcomes in older women with ovarian cancer.
    van der Zanden V; van Soolingen NJ; Viddeleer AR; Trum JW; Amant F; Mourits MJE; Portielje JEA; van den Bos F; de Kroon CD; Kagie MJ; Oei SA; Baalbergen A; van Haaften-de Jong ALD; Houtsma D; van Munster BC; Souwer ETD
    Gynecol Oncol; 2021 Aug; 162(2):360-367. PubMed ID: 34112514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced ovarian cancer and cytoreductive surgery: Independent validation of a risk-calculator for perioperative adverse events.
    Straubhar AM; Wolf JL; Zhou MQC; Iasonos A; Cham S; Wright JD; Long Roche K; Chi DS; Zivanovic O
    Gynecol Oncol; 2021 Feb; 160(2):438-444. PubMed ID: 33272645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications and Survivorship Trends After Primary Debulking Surgery for Ovarian Cancer.
    Xu Z; Becerra AZ; Justiniano CF; Aquina CT; Fleming FJ; Boscoe FP; Schymura MJ; Sinno AK; Chaoul J; Morrow GR; Minasian L; Temkin SM
    J Surg Res; 2020 Feb; 246():34-41. PubMed ID: 31561176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and outcomes after bowel surgery and ostomy formation at the time of debulking surgery for advanced-stage epithelial ovarian carcinoma.
    Gockley AA; Fiascone S; Hicks Courant K; Pepin K; Del Carmen M; Clark RM; Goldberg J; Horowitz N; Berkowitz R; Worley M
    Int J Gynecol Cancer; 2019 Mar; 29(3):585-592. PubMed ID: 30833444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and risk factors of early postoperative small bowel obstruction in patients undergoing hysterectomy for benign indications.
    Sheyn D; Bretschneider CE; Mahajan ST; Ridgeway B; Davenport A; Pollard R
    Am J Obstet Gynecol; 2019 Mar; 220(3):251.e1-251.e9. PubMed ID: 30471258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): a feasibility study.
    Gueli Alletti S; Bottoni C; Fanfani F; Gallotta V; Chiantera V; Costantini B; Cosentino F; Ercoli A; Scambia G; Fagotti A
    Am J Obstet Gynecol; 2016 Apr; 214(4):503.e1-503.e6. PubMed ID: 26529370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative fluid balance and major postoperative complications in surgery for advanced epithelial ovarian cancer.
    Hasselgren E; Hertzberg D; Camderman T; Björne H; Salehi S
    Gynecol Oncol; 2021 May; 161(2):402-407. PubMed ID: 33715894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bowel resection or repair at the time of cytoreductive surgery for ovarian malignancy is associated with increased complication rate: An ACS-NSQIP study.
    Bernard L; Boucher J; Helpman L
    Gynecol Oncol; 2020 Sep; 158(3):597-602. PubMed ID: 32641239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of advanced ovarian cancer in South West Wales - a comparison between primary debulking surgery and primary chemotherapy treatment strategies in an unselected, consecutive patient cohort.
    Drews F; Bertelli G; Lutchman-Singh K
    Cancer Epidemiol; 2017 Aug; 49():85-91. PubMed ID: 28599137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.